As a kidney transplant recipient and patron of the International Society of Nephrology, Prince Daniel has a strong focus on health-related topics and is committed to raising global awareness for kidney disease.
Join colleagues from more than 100 countries around the world for the Life/2021 nephrology congress and learn about new perspectives, innovative technologies, and disruptive trends from visionaries in the field.
Access all keynote and breakout sessions on the virtual platform of the Life/2021 nephrology campus. In her daily Life/TV clips Kristina zur Muehlen will guide you through the educational platform, the program and special highlights. Find out more - you are warmly invited to tune in!
In nephrology, healthcare professionals work together as a close team - to reflect this, we are delighted and honored to announce that the Life/2021 nephrology congress will include a specially designed stream dedicated to the role of the nurse in dialysis.
Under the motto "Nursing Leadership 2.0", the sessions will share success stories and cover novel renal nursing topics, such as operational crisis management, new challenges in patient care, critical issues of decision making, assuming a leadership role with responsibility and ownership.
The hot topic of home dialysis in pandemic times and beyond will also be discussed from a nursing perspective. How has the pandemic impacted home dialysis patients? Find out about the challenges faced, lessons learned, solution-focused thinking and a vision for the future.
The global COVID-19 pandemic has exposed the fundamental need to identify new ways of digital networking, international collaboration and open access science. As a result, Life/2021 nephrology congress is a fully virtual educational symposium, streamlining global attendance from one's home or workplace, while lowering our carbon footprint and contributing to a more sustainable tomorrow. Moreover, the new virtual engagement models enable physicians, nurses and kidney patients to pave the way for the future of personalized kidney care.
Join the international faculty and gain expertise from over 80 highly renowned physicians, nurses and scientists in the field of nephrology. Learn about current and future approaches to personalized kidney care, shared decision making, preventing myocardial stunning, novel strategies to improve patient outcome, maintenance of renal residual function, minimization of intradialytic hypotension, smart wearable sensors, precise nutritional intervention, leveraging large patient data sets and improved therapy guidance to improve global kidney care!
Do we need public strategies to promote kidney health and enable access to care around the world? How can we ensure that treatment is offered to the right patient at the best time? In the introductory session to the Life/2021 congress two distinguished speakers: Prof. Adeera Levin, former ISN president, and Prof. Dick de Zeeuw, renowned principal investigator of many global kidney disease clinical studies, will discuss recent findings and bring them into perspective.
Aging is not only associated with increased wisdom and experience, but also with a decline in physical functions including vascular calcification, heart failure, osteoporosis, muscle loss, frailty, depression and cognitive disorders. CKD with accumulation of uremic toxins and increased modification of proteins leads to premature occurence of aging. Prof. Peter Stenvinkel, chairman of the Life/2021 conference has dedicated his work to understand the molecular and physiological mechanisms behind this phenomenon and thereby create a foundation for treatments and diagnostics.
Presently available information suggests that Online hemodiafiltration (HDF) is associated with an improved clinical outcome when compared to standard hemodialysis. However, definite proof is lacking and information on the effects on patient reported outcome measures is very limited. Prof. Peter Blankestijn, principal investigator of CONVINCE will share insights and current status of this global clinical trial, which is supported by the Horizon 2020 program of the European Commission.
Despite the tremendous efficacy of several new drug classes such as SGLT2-inhibitors, endothelin receptor antagonists, and mineralocorticoid receptor antagonists on a population level, not every patient benefits to the same extent. Understanding the underlying mechanisms for the variation in drug response will pave the way for personalized therapy approaches. Prof. Hiddo Lambers-Heerspink is maintainer of personalized medicine by optimizing and finding new therapeutic approaches to halt the progression of renal and cardiovascular diseases in patients with diabetes.
Prof. Urnov is a specialist in genome editing with CRISPR-Cas9 which has transformed therapeutic advances in kidney care. The impact of gene therapy and immunotherapy already allows for first patient success stories for which Prof. Urnov’s colleagues Jennifer Doudna and Emmanuelle Charpentier received the Nobel Prize in Chemistry in 2020 for their pioneering work on CRISPR-Cas9. Along with such novel therapies, there is an urgent need to make such cures cost-effective and accessible for patients.
Join the session and learn more about the applications of CRISPR-Cas9 in kidney disease and therapies with Prof. Fyodor Urnov as well as Dr. Michael Curtis (President of R&D at eGenesis - project lead in the xenotransplantation program) and Ms. Fiona Loud (Policy Director, Kidney Care UK).
Dialysis therapy is lifesaving to approximately 3.4 million people worldwide. However, the chronic kidney disease (CKD) treatment is enormously complex and novel approaches are constantly emerging. The 4-day program of the Life/2021 nephrology congress aims to put CKD patients at the center of all efforts by creating interactions among disciplines. It covers numerous state-of-the-art clinical and research topics.
Explore how the Life/2021 nephrology congress can help you prepare for customized kidney disease care - And make sure not to miss the personal greeting from Life/2021 chairman Prof. Christoph Wanner at the end of the clip.
Join the movement specialists for our Life/health body and mind program!
is a certified yoga teacher specialized in healthy movement and pain management. Joëlle draws from her own experience of living with fibromyalgia for over two decades to adapt her classes to best suit her students’ capabilities. She believes that yoga is for everyone and can help nearly anyone feel better, no matter their situation.
Kim Saha/United Kingdom
is a qualified physiotherapist and a certified pilates instructor. Kim has gathered a wealth of experience in helping people with injuries to release chronic pain thanks to her work in a physiotherapy clinic and by providing emergency medical care for the British Athletics Team. Having researched CKD, she is thrilled to use her great expertise to help patients suffering from this disease.
Yoga and Pilates practice significantly benefit both body and mind
There is already clear scientific evidence that regular physical exercise not only protects against the onset of serious illnesses. It can also improve the well-being of people suffering from chronic diseases.
Yoga and Pilates encompass physical postures, breathing, meditation and relaxation techniques which are feasible even for physically limited patients. It is therefore not surprising to learn that Yoga can also improve the clinical picture of CKD, as shown in a 6-month long clinical trial.(1, 2)
Recognizing that kidney patients are keen to learn about suitable exercises they can do at home, the Life/2021 program includes a series of active breaks that will provide participants with information and practical demonstrations. Our body movement experts Joëlle Fixson and Kim Saha have developed special training sessions that can be adapted to the individual health conditions of CKD patients.
1) Pandey RK et al. 2017 Intern J of Yoga Vol. 10(1), pp. 3-8
2) Yurtkuran M et al. 2007 Compl Methods in Medicine Vol. 15(3), pp. 164-171
Follow the conversation between the experts in this special keynote session
"Understanding cellular oxygen sensing mechanisms: implications for medicine"
on Wednesday, September 15, 2021
Sir Peter Ratcliffe was awarded the Nobel Prize in Physiology or Medicine in 2019 together with William G. Kaelin Jr and Gregg L. Semenza. He is the first nephrologist to receive this prestigious prize. The three pioneers discovered the hypoxia-inducible factor (HIF), elucidated the oxygen sensing mechanism of cells, and confirmed the critical role of HIF in hypoxic cellular responses. The broad and profound biological effects of HIF open up possibilities for clinical translation, and in particular how to stimulate endogenous erythropoietin production. While Sir Peter Ratcliffe’s research laid the foundation for the molecular understanding of HIF-inhibitors, Prof. Kai-Uwe Eckardt investigated this compound class in phase III clinical studies. HIF stabilizers, such as the HIF-inhibitor Vadadustat, have been proven effective for the treatment of anemia of chronic kidney disease in phase III clinical trials.
Learn from their experience and do not miss this exclusive session!
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. Please note: An administrative CME certification handling fee of 15 EUR + VAT will be charged in order to receive ECMEC®s.